Biotech

Biotechnology, gene editing, biopharma platforms, and clinical pipelines.

  • 9 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Biotech


daily-tribune.com-tribune.com

Travere Therapeutics Announces Planned Chief Executive Officer Transition

3+ hour, 36+ min ago   (868+ words) The Daily Tribune News Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that Eric Dube, Ph.D., has made the difficult and personal decision to step down as president and chief executive officer to focus on his health and family. The Companyâ…...


kansascity.com > news > business > article317329427.html

Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on

1+ hour, 52+ min ago   (328+ words) Sept 21 (Reuters) - Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of biotech listings in the fall window. While the fall IPO…...


biobuzz.io > news > novo-nordisk-and-anthropic-announce-collaboration-to-advance-drug-discovery-with-claude

Novo Nordisk and Anthropic Announce Collaboration to Advance Drug Discovery With Claude

2+ hour, 12+ min ago   (404+ words) BioBuzz Novo Nordisk and Anthropic Announce Collaboration to Advance Drug Discovery With Claude Novo Nordisk and Anthropic announced a collaboration on September 16, 2026 aimed at helping Novo accelerate the development of new medicines and advance AI-driven software development. The companies will…...


biobuzz.io > news > people-on-the-move-edwin-beale-named-chief-commercial-officer-of-kincellis-advanced-therapies

People on the Move: Edwin Beale Named Chief Commercial Officer of Kincellis Advanced Therapies

6+ hour, 47+ min ago   (389+ words) BioBuzz People on the Move: Edwin Beale Named Chief Commercial Officer of Kincellis Advanced Therapies Edwin Beale has been named Chief Commercial Officer of Kincellis Advanced Therapies, the cell therapy CDMO formed this month through the merger of Kincell Bio…...


iambic.ai > post > abbvie-and-iambic-announce-collaboration-to-accelerate-ai-driven-drug-discovery

AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery

6+ hour, 35+ min ago   (360+ words) Iambic Therapeutics − Multi-year partnership applies Iambic’s AI platform to speed up small molecule drug discovery in immunology, neuroscience and oncology “Combining Iambic's platform with the drug hunting expertise of AbbVie scientists can help us make more precise decisions about the…...


m.economictimes.com > industry > healthcare > biotech > healthcare > ichor-biologics-seeks-80-100-million-pe-funding-for-minority-stake-sale > amp_articleshow > 134396496.cms

Ichor Biologics seeks $80-100 million PE funding for minority stake sale

5+ hour, 7+ min ago   (228+ words) Don’t allow US to weaponise space: From Reagan’s ‘Star Wars’ to Trump’s space weapons push Florida doesn't know where invasive giant Burmese pythons are hiding in the Everglades. So scientists are following the males Meet Teodor Zajder, the 9-year-old Polish…...


marketscreener.com > news > moderna-provides-details-on-data-presentations-at-upcoming-conferences-ce785adbd18bff21

Moderna Provides Details on Data Presentations at Upcoming Conferences

3+ hour, 26+ min ago   (47+ words) Published on 09/21/2026 at 04:14 pm EDT Moderna Soars 129% for the Week | Closing Bell August 21, 2026 at 05:02 pm EDT Will Moderna Wake Up the Health Care Sector? Moderna and Merck & Co are the stocks of the day on Wall Street...


pulse2.com > s2s-china-selects-10-biotech-finalists-to-pitch-global-investors-at-westlake-university

S2S China Selects 10 Biotech Finalists To Pitch Global Investors At Westlake University

5+ hour, 8+ min ago   (275+ words) RA Capital Management and Qiming Venture Partners have selected 10 biotech startup teams as finalists for the inaugural S2S China Symposium, an initiative designed to connect academic therapeutics research in China with global biotechnology investors. S2S China is the China chapter of Science2Startup, an…...


tradingview.com > news > tradingview:b3430d63ef810:0-carter-s-limited-duration-stockholder-rights-agreement-expired-rights-no-longer-exercisable

Carter's limited-duration stockholder rights agreement expired; rights no longer exercisable

3+ hour, 18+ min ago   (87+ words) TradingView Carter's limited-duration stockholder rights agreement expired; rights no longer exercisable Carter's announced the expiration of its limited-duration stockholder rights agreement and that associated preferred stock purchase rights are no longer exercisable. - Rights Agreement dated Sept. 22, 2025 expired on Sept. 21, 2026 in…...